Prisym ID’s Clinical Trial Solution Chosen for Medicines Manufacturing Innovation Centre Project

Label management specialist, Prisym ID, announced in a Nov. 19, 2019 press release that its clinical trial solution, PRISYM 360, has been chosen by CME to be part of a just in time clinical trials handling system for the Medicines Manufacturing Innovation Centre project.

The Medicines Manufacturing Innovation Centre will be located in Renfrewshire, Scotland, and is being funded by the United Kingdom Research and Innovation (UKRI) and Scottish Enterprise. The Centre for Process Innovation (CPI) will lead the center in partnership with the University of Strathclyde and founding industry partners, AstraZeneca and GlaxoSmithKline.

It is the aim of the center to become an international beacon for innovation in small molecule medicines manufacturing. Incorporating capabilities for development and manufacturing of drug substances and drug products in a good manufacturing practice environment, will enable the center to guarantee just in time, right first time, and real-time release manufacturing principles.

“Prisym ID were an obvious fit for the system because their solution is able to meet the very demanding requirements for print verification over a huge range of languages,” said Paul Simmons, engineering director at CME in the press release. “The company is also very used to producing a fully validated system with full traceability-another key requirement for this system.”

Steve Ellison, vice-president of clinical trials at Prisym ID added, in the press release, “We are thrilled to be part of such an exciting industry project and to contribute to innovations which will help bring new treatments to market more quickly for the benefit of patients. PRISYM 360 ensures that creation of the label content at time of print achieves the performance required for production in a GMP compliant just in time environment.”

Source: Prisym ID